Cosmetic cross-reference Noindex: medium evidence

627-93-0

CAS 627-93-0

627-93-0 (CAS 627-93-0) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
1
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
627-93-0
CAS Number
627-93-0
UNII
BY71RX0R62
InChIKey
UDSFAEKRVUSQDD-UHFFFAOYSA-N
ChEMBL ID
CHEMBL1566491
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- Potency 15172.275000000001 nM 8 -
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 627-93-0 used for in pharmaceutical contexts?

627-93-0 (CAS 627-93-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 627-93-0?

No adverse-event association or SIDER side-effect rows are rendered for 627-93-0 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 627-93-0 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Dimethyl Adipate with EU status "permitted".

What clinical phase is 627-93-0 in?

No phase 1-4 clinical development badge is rendered for 627-93-0 because the matched compound identifier rows do not contain a max-phase value.